PAR paradigm biopharmaceuticals limited..

FDA delay for ph 3 trial approval, page-4

  1. 474 Posts.
    lightbulb Created with Sketch. 107
    It was 'imminent' five weeks ago according to Paul Rennie. One wonders what difficulties PAR has created for the FDA.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.005(1.15%)
Mkt cap ! $170.8M
Open High Low Value Volume
43.5¢ 43.5¢ 40.5¢ $532.2K 1.265M

Buyers (Bids)

No. Vol. Price($)
1 4500 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 9422 3
View Market Depth
Last trade - 16.10pm 10/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.